NCAM1 and glioma: We highlighted that the neural and glioma cancer stem cell marker CD56 (36, 47, 48) and the integrin β1, CD29 (40–42) were more uniformly expressed within the hemispheric subgroup, regardless of their histone alterations (Figures 4A, B).